FTC sues main pharmacy advantage supervisors more than insulin selling prices The agency introduced motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing price of life-saving insulin prescription drugs. Earlier this summertime, the agency held prolonged negotiations with https://buschlightpeachnutritionf83827.blogacep.com/35827948/about-healthcare-news